Improvement of glycemic control by treatment for insomnia with suvorexant in type 2 diabetes mellitus

Improvement of glycemic control by treatment for insomnia with suvorexant in type 2 diabetes mellitus

Introduction: Acute and chronic insomnia can exacerbate type 2 diabetes mellitus (T2DM). We investigated suvorexant (an anti-insomnia drug that targets the orexin system) effects on sleep architecture and glucose metabolism in T2DM patients with insomnia. Materials and methods: This 7 day open-label...

Full description

Bibliographic Details
Main Authors: Norikazu Toi, Masaaki Inaba, Masafumi Kurajoh, Tomoaki Morioka, Noriyuki Hayashi, Tomoe Hirota, Daichi Miyaoka, Masanori Emoto, Shinsuke Yamada
Format: Article
Language:English
Published: Elsevier 2019-03-01
Series:Journal of Clinical & Translational Endocrinology
Online Access:http://www.sciencedirect.com/science/article/pii/S221462371830139X

Internet

http://www.sciencedirect.com/science/article/pii/S221462371830139X

Similar Items